Relay Therapeutics is trading 5% up at $20.68 in after-hours trading after H.C. Wainwright raised its price target to $29 on August 20, 2026.
- After-hours activity appears notable: the rebound followed the regular-session close of $19.70 and reversed the session’s 5.01% decline.
- Major U.S. indices declined, so the positive extended-hours move appears primarily tied to the upgraded target.
- Results released August 6 are less likely to explain the move.